We focus on life science companies that can provide
exceptional value to patients, clinicians or providers.
Guided by our experience as industry professionals
and venture capital investors, we invest in medical
device, biotechnology and diagnostic companies developing
breakthrough products and therapies. We do not consider
healthcare information technology or service opportunities.
Stage and Geographic focus:
By virtue of our regional presence and capital funding,
Triathlon is one of the leading sources of early-stage
life science investment capital in the Midwest. We
make investments in early-stage opportunities, typically
when there are only a few employees and great idea.
We look for a solid business plan with a unique solution
to an unmet medical need, and experienced management.
For these early stage opportunities we invest exclusively
in the Midwest.
We also invest nationally in mid- to later-stage
life science companies that meet the same strategic,
technical and business criteria. However these companies
should already have a seasoned management team in
place that is effectively executing the business vision,
a clear proof of clinical efficacy, and an existing
knowledgeable, committed, and well-capitalized investor